SCHEMBL13349409

SCHEMBL13349409

CCOc1cccc2cc(N3CC(c4ccc(C)cc4)N=N3)c(=O)oc12

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA3 P0DMS8 6/20 0.53
▸ TP53 P04637 2/20 0.48
▸ HSD17B10 Q99714 2/20 0.48
▸ LMNA P02545 2/20 0.48
▸ NPC1 O15118 1/20 0.48
▸ ALDH1A1 P00352 1/20 0.48
▸ ESR1 P03372 1/20 0.48
▸ CASP1 P29466 1/20 0.48
▸ RAB9A P51151 1/20 0.48
▸ SMN1; SMN2 Q16637 1/20 0.48
▸ ADORA2A P29274 1/20 0.47
▸ ADORA1 P30542 1/20 0.47
▸ CA12 O43570 2/20 0.45
▸ CA2 P00918 2/20 0.45
▸ CA9 Q16790 2/20 0.45
▸ CA1 P00915 1/20 0.45
▸ MAPT P10636 2/20 0.43
▸ RXFP1 Q9HBX9 1/20 0.43
▸ USP2 O75604 2/20 0.42
▸ PPARG P37231 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13315807 0.71 ADORA3 (0.61) ADORA3TP53HSD17B10LMNANPC1
SCHEMBL18563010 0.70 RAB9A (0.44) TP53HSD17B10LMNANPC1ALDH1A1
SCHEMBL21033123 0.69 RXFP1 (0.83) ADORA3TP53HSD17B10LMNANPC1
SCHEMBL830725 0.64 CA12 (0.82) ADORA3TP53HSD17B10LMNANPC1
SCHEMBL1368826 0.64 PPARG (0.64) ADORA3HSD17B10NPC1ALDH1A1ADORA2A
SCHEMBL1368062 0.64 PPARG (0.64) ADORA3HSD17B10NPC1ALDH1A1ADORA2A
SCHEMBL266604 0.64 ADORA3 (0.58) ADORA3TP53HSD17B10LMNANPC1
SCHEMBL981636 0.63 CA12 (0.73) ADORA3HSD17B10NPC1ALDH1A1ADORA2A
SCHEMBL11152052 0.63 ADORA3 (0.61) ADORA3TP53HSD17B10LMNANPC1
SCHEMBL20435664 0.63 CA12 (0.70) ADORA3HSD17B10LMNAALDH1A1ADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7745229-B2 Chemoselective fluorgenic molecular linkers and methods for their preparation and use UNIVERSITY OF SOUTH CAROLINA 2010-06-29 — — US disclosed
US-20070224695-A1 Chemoselective Fluorgenic Molecular Linkers and Methods for Their Preparation and Use UNIVERSITY OF SOUTH CAROLINA (US) 2007-09-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070224695-A1 Chemoselective Fluorgenic Molecular Linkers and Methods for Their Preparation and Use KIT, HLCS, ALK ADORA3 2791/4885TP53 863/4885HSD17B10 4350/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback